返回产品
威格顿生物 徐州威格顿生物科技有限公司
威格顿生物
威格顿生物 Weigedun Biotechnology
产品说明书

BLVRB Mouse mAb

货号WGD-Z-2611325 更新日期2026-08-30
规格信息
规格货号
50ul WGD-Z-2611325
100ul WGD-Z-2611325
详细参数
别名 Flavin reductase; NADPH; FR; Biliverdin reductase B; BVR-B; Biliverdin-IX beta-reductase; Green heme-binding protein; GHBP; NADPH-dependent diaphorase; NADPH-flavin reductase; FLR; S-nitroso-CoA-assisted nitrosyltransferase; SNO-CoA-assisted nitrosyltransferase
基因名 BLVRB
UniProt ID P30043
反应种属 Human
应用 WB
宿主 Mouse
偶联物 Unconjugated
修饰 Unmodified
亚型 IgG2b
克隆号 5P6-H1-R8
克隆性 Monoclonal Antibody
分子量 Calculated MW: 22 kDa
纯化方式 Affinity Purified
产品形式 Liquid
推荐稀释比 WB-1:1000
存储缓冲液 Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.09% sodium azide
保存温度 Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.
背景信息 Biliverdin reductase B (BLVRB) is a monomeric enzyme that functions as a critical cellular redox regulator by catalyzing the NADPH-dependent reduction of various substrates, including biliverdin and flavins. It features a dinucleotide-binding fold that undergoes conformational changes upon coenzyme binding to facilitate its catalytic activity. Beyond its role in maintaining redox homeostasis, BLVRB exhibits dual-specificity kinase activity and participates in cell signaling pathways that defend against oxidative stress and endothelial dysfunction. The enzyme's promiscuous catalytic nature allows it to dictate cellular fate under different physiological conditions. Clinically, BLVRB is recognized as a potential target for managing neonatal jaundice and as an adjunct therapy in organ transplantation to maintain protective biliverdin levels.